Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
H1N1 Influenza
Interventions
OTHER

Empirical antimicrobial therapy

All patients with pulmonary symptoms received empirical antimicrobial therapy with ceftriaxone and rovamycin or levofloxacin on admission and this was subsequently adapted to any documented bacterial infection if positive.

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03641690 - Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter